Immuron submits Coffee Microcaps Conference presentation##

Bitget2026/09/22 10:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Immuron published an investor presentation tied to CEO Steven Lydeamore’s Coffee Microcaps Conference slot on Sept. 22, 2026.
Slides outline Travelan, an oral passive immunotherapy positioned to reduce the risk of travelers’ diarrhea caused by pathogenic bacteria.
Pipeline summary highlights IMM-529 for recurrent C. difficile infection as an adjunct to antibiotics, targeting toxin B, spores, surface proteins.
Presentation also covers ProIBS distribution in Australia and New Zealand, describing it as a medical device for IBS symptoms.
Links cited: https://www.immuron.com.au/ | https://www.travelan.com

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-101907), on September 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Immuron submits Coffee Microcaps Conference presentation##

You may also like

Crypto prices